Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
- PMID: 8339264
Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
Abstract
The squamous mucosa of patients who develop head and neck cancer is "condemned" or predisposed to disregulated growth as reflected by the high incidence of synchronous and metachronous primary tumors. We hypothesized that transformed and nontransformed mucosa from head and neck cancer patients would produce increased levels of transforming growth factor alpha (TGF-alpha) and its cell surface receptor, the epidermal growth factor receptor (EGFR), thereby contributing to this predisposition. Using molecular biological techniques, we examined the incidence and mechanism of TGF-alpha and EGFR overproduction in tumors and histologically normal mucosa excised from patients with squamous cell carcinoma of the head and neck (SCCHN) to test this hypothetical mechanism of field cancerization. Northern blot hybridization was used to evaluate the frequency of increased TGF-alpha and EGFR mRNA production in tissue excised from 24 patients with SCCHN and 10 cell lines compared with 7 control patients without cancer or a history of alcohol and tobacco use. Southern blot hybridization was used to examine for gene amplification. In patients with SCCHN, TGF-alpha mRNA was elevated by a mean of 5-fold in 95% of histologically "normal" mucosa samples (P = 0.001) and by a mean of 5-fold in 87.5% of tumors (P = 0.0001) while EGFR mRNA was elevated by a mean of 29-fold in 91% of histologically normal mucosa specimens (P = 0.0005) and by a mean of 69-fold in 92% of tumors (P = 0.0005), compared with mRNA levels in control normal mucosa. In 10 SCCHN cell lines, TGF-alpha mRNA was increased by a mean of 16-fold and EGFR mRNA levels were increased by a mean of 77-fold. Increased production of TGF-alpha and EGFR mRNA in the histologically normal mucosa of patients at risk for a primary or secondary head and neck cancer may serve both as a marker for malignant transformation and as a target for preventive therapies.
Similar articles
-
Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.Cancer. 1996 Sep 15;78(6):1284-92. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X. Cancer. 1996. PMID: 8826952
-
Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.Oncogene. 1997 Jul 24;15(4):409-16. doi: 10.1038/sj.onc.1201188. Oncogene. 1997. PMID: 9242377
-
Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer.Anticancer Res. 1996 Jan-Feb;16(1):283-8. Anticancer Res. 1996. PMID: 8615622
-
STAT signaling in head and neck cancer.Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review.
-
The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.Dan Med Bull. 1998 Apr;45(2):121-34. Dan Med Bull. 1998. PMID: 9587699 Review.
Cited by
-
A mRNA-Responsive G-Quadruplex-Based Drug Release System.Sensors (Basel). 2015 Apr 21;15(4):9388-403. doi: 10.3390/s150409388. Sensors (Basel). 2015. PMID: 25905703 Free PMC article.
-
Oral field cancerization: current evidence and future perspectives.Oral Maxillofac Surg. 2012 Jun;16(2):171-80. doi: 10.1007/s10006-012-0317-x. Epub 2012 Feb 22. Oral Maxillofac Surg. 2012. PMID: 22354325 Review.
-
Targeted therapy in head and neck cancer.Tumour Biol. 2012 Jun;33(3):707-21. doi: 10.1007/s13277-012-0350-2. Epub 2012 Feb 29. Tumour Biol. 2012. PMID: 22373581 Review.
-
Recent advances in the molecular biology of head and neck tumours.Indian J Otolaryngol Head Neck Surg. 1999 Oct;51(4):10-8. doi: 10.1007/BF03022707. Indian J Otolaryngol Head Neck Surg. 1999. PMID: 23119562 Free PMC article.
-
The role of EGFR-targeting strategies in the treatment of head and neck cancer.Onco Targets Ther. 2012;5:127-31. doi: 10.2147/OTT.S31863. Epub 2012 Jul 27. Onco Targets Ther. 2012. PMID: 22888261 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous